Abstract:Objective To explore the value of hyperbaric oxygen therapy (HBOT) on relieving the clinical symptoms in elderly coronary heart disease (CHD) patients with unstable angina (UA), and to investigate its impact on peripheral blood D-dimer (D-D), blood lipid metabolism and vascular inflammatory factors. Methods A total of 146 elderly CHD patients with UA admitted to our hospital from June 2021 to December 2023 were recruited and randomly divided into HBOT group (HBOT+ basic treatment, n=73) and control group (basic treatment, n=73). Both groups of patients were continuously intervened for 15 d. The therapeutic effect, as well as peripheral blood levels of D-D, blood lipids and vascular inflammatory factors [high-sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2), homocysteine (Hcy)] before and after treatment were determined and compared between two groups. The frequency and duration of angina pectoris on the second day after admission and on the first day before discharge were counted in both groups. SPSS 26.0 was used for data analysis, and t test or χ2 test was carried out depending on data type. Results In the HBOT group, six patients withdrew due to poor adaptation to HBOT treatment and cost of HBOT, and the remaining 67 patients completed 15 d of treatment. All the patients in the control group completed 15 d of treatment. After treatment, the levels of blood lipids, TG and plasma D-D in the HBOT group were decreased than the levels before treatment, while the HDL-C was enhanced than the levels before treatment; the plasma D-D were significantly lower while the HDL-C were significantly higher in the HBOT group than the control group (P<0.05). The levels of blood lipid indicators and plasma D-D in the control group were not notably improved after treatment (P>0.05). After treatment, the levels of vascular inflammatory factors hs-CRP, Lp-PLA2 and Hcy were decreased in both groups, and the average daily frequency of angina pectoris attacks and duration of angina pectoris in both groups were reduced on the first day before discharge compared with those on the second day after admission. The levels of vascular inflammatory factors and average daily frequency and duration of angina pectoris attacks were significantly lower in the HBOT group than the control group after treatment (P<0.05). The effective rate of treatment was significantly higher in the HBOT group than the control group [92.54% (62/67) vs 80.82% (59/73), P<0.05]. Conclusion HBOT has good efficacy in reducing the frequency of angina pectoris attacks and the duration of angina pectoris. Besides the traditional mechanism, HBOT may also play a therapeutic effect by reducing the releases of vascular inflammatory factors and improving the lipid metabolism disorder and hypercoagulable state.